Homeopathic medicinal products (individualised treatment) vs placebo or usual care: Recurrence of ARTI
Homeopathic medicinal products (individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Homeopathic medicinal products (individualised treatment) vs placebo or usual care Recurrence of ARTI · children aged up to 16 years with ARTIs Homeopathic medicinal products (individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (moderate certainty). Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane Headline outcomes only | OR 1.31 [0.64, 2.7] | 1 study · 199 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.